HHS aims to use value-based care payment models to lower drug prices

September 9, 2021Garrett SchmittNo CommentsCMMI, drug prices, HHS, Pharmaceuticals

The Department of Health and Human Services wants to test models that would pay drugs based on their clinical value as part of a new plan to tackle high prices. The plan released Thursday lays out several administrative tools the agency plans to take to address high prices. It also calls on Congress to adopt several reforms…

Recent Posts

  • Dementia Care as Strategic Infrastructure: Why ACOs Must Elevate It Now
  • RECORDED WEBINAR: Driving alignment at scale: A health system’s approach to technology implementation
  • As CMS Expands ACOs, Nursing Homes Push for More Aligned Model as 90% Are Left Out
  • NAACOS to CMS: Bring Innovations From Other APMs to MSSP
  • Value-based care company acquires MSO
 
  • Main Lobby
  • Exhibit Hall
  • Events
  • Exhibit With Us
  • Board Room
  • Library
  • Contact Us